Haematotoxicity during peptide receptor radionuclide therapy: Baseline parameters differences and effect on patient’s therapy course

BACKGROUND: Mainly severe (CTCAE grade 3–4) haematotoxicity during peptide receptor radionuclide therapy (PRRT) is reported in literature due to major clinical impact, however moderate (CTCAE grade 2) haematotoxicity is common and could affect therapy management. The aim of this study was to evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales: de Vries–Huizing, Daphne M. V., Versleijen, Michelle W. J., Sinaasappel, Michiel, Walraven, Iris, Geluk–Jonker, Martine M., Tesselaar, Margot E. T., Hendrikx, Jeroen J. M. A., de Wit–van der Veen, Berlinda J., Stokkel, Marcel P. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601524/
https://www.ncbi.nlm.nih.gov/pubmed/34793530
http://dx.doi.org/10.1371/journal.pone.0260073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601524/
https://www.ncbi.nlm.nih.gov/pubmed/34793530
http://dx.doi.org/10.1371/journal.pone.0260073

Ejemplares similares